U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07335679) titled 'Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma' on Jan. 02.
Brief Summary: Adrenal corticosteroid carcinoma (ACC) is a rare tumor of the adrenal cortex, with an estimated prevalence of 0.5 to 2 cases per million inhabitants per year.
Two peaks in incidence have been described: during the first decade of life and between 40 and 50 years of age, with a slight female predominance (female-to-male ratio of 1.5). The majority of cases (>90%) are sporadic, particularly in adults.
ACC may be discovered incidentally during an imaging examination performed for another reason (10 to 20% of cases) or in co...